Stock Comparison
JNJ vs MO: Which Is the Better Pick in 2026?
A head-to-head comparison of Johnson & Johnson and Altria Group, Inc. covering yield, cost, risk, and income potential.
Data updated September 4, 2026
Best for
- JNJInvestors who want direct ownership of the underlying business, with no fund wrapper or management fee.
- MOInvestors who want higher current income (6.10% vs 1.92% for JNJ).
Visual comparison
Key metrics
Projected income on $10K
Projections assume the current yield and share price remain constant. Actual results will vary.
Total returns
JNJ has outpaced MO over the trailing twelve months, posting a 58.12% total return against 10.39%. The lead holds up over 10 years too: JNJ has compounded at 11.68% a year, against 7.32% for MO. Figures are total returns: price change plus every distribution reinvested.
| Symbol | YTD | 1Y | 3Y | 5Y | 10Y | Since Nov 1984 | Volatility | Sharpe | Sortino | Max drawdown |
|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | 34.89% | 58.12% | 23.12% | 12.57% | 11.68% | 14.65% | 18.0% | 0.91 | 1.33 | -14.4% |
| MO | 24.03% | 10.39% | 25.24% | 14.74% | 7.32% | 27.45% | 21.5% | 0.84 | 1.16 | -16.4% |
Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of September 4, 2026. YTD and 1Y are cumulative; windows of one year or longer are annualized. “Since Nov 1984” measures every fund from November 5, 1984 — the youngest fund's first trading day — so all funds share one comparison window. Volatility is the annualized standard deviation of daily total returns over the trailing 3 years. Sharpe and Sortino divide the annualized return in excess of the risk-free rate by, respectively, that volatility and the downside deviation (both over the trailing 3 years) — higher is better. Max drawdown is the largest peak-to-trough total-return decline over the same window — shallower is better.
Side-by-side snapshot
| Metric |  JNJ |  MO |
|---|---|---|
| Full name | Johnson & Johnson | Altria Group, Inc. |
| Issuer | — | — |
| Last Close | $275.23 as of September 4, 2026 | $68.88 as of September 4, 2026 |
| Distribution yield | 1.92% | 6.10% |
| Distribution Safety Score™ | 100 | 97 |
| Safety-Adjusted Yield | 1.92% | 5.92% |
| Expense ratio | — | — |
| AUM | — | — |
| Distribution frequency | Quarterly | Quarterly |
| Underlying index | — | — |
| Objective | Researches, develops, manufactures, and sells healthcare products including pharmaceuticals, medical devices, and consumer health products worldwide. | Manufactures and sells cigarettes, oral tobacco products, and wine in the United States through subsidiaries including Philip Morris USA and John Middleton. |
| Asset class | Equity | Equity |
| Inception date | N/A | N/A |
| Beta | 0.231 | 0.495 |
| Last dividend | $1.34 declared, pays 09/08/2026 | $1.11 declared, pays 10/09/2026 |
| Ex-dividend date | 08/25/2026 | 09/15/2026 upcoming |
Bottom lineChoose JNJ if you want direct ownership of the underlying business, with no fund wrapper or management fee. Choose MO if you want higher current income (6.10% vs 1.92% for JNJ).
Income calculator
See how much monthly income a hypothetical investment would generate in each stock at current yields.
Want to go deeper?
Add these stocks to a sample portfolio and forecast your dividend income over 5+ years — free to start, no credit card.
Quick verdict
JNJ (Johnson & Johnson) and MO (Altria Group, Inc.) are both quarterly-pay dividend-paying stocks, but they take different approaches.
MO offers the higher yield at 6.10% vs 1.92% for JNJ. A higher yield means more current income per dollar invested, though it may come with different risk characteristics.
Who should choose each?
Choose JNJ
Johnson & Johnson
- Want direct stock ownership — full upside and dividend growth potential, no fund wrapper or expense ratio.
- Prefer lower volatility — a beta of 0.2 vs 0.5 for MO.
Choose MO
Altria Group, Inc.
- Want higher current income — MO yields 6.10% vs 1.92% for JNJ.
- Want direct stock ownership — full upside and dividend growth potential, no fund wrapper or expense ratio.
Not sure? Use the income calculator and snapshot above to weigh these trade-offs against your own goals.
Still deciding? Track JNJ & MO for free
Create a free Dividend Vision account to keep them on a watchlist, get notified when they declare dividends, and see how much income they would add to your portfolio.
Deep dive
Yield & income
On a $10,000 investment, JNJ would generate roughly $16.00/month, while MO would produce $50.83/month, at current distribution rates. Both pay quarterly distributions.
Strategy & risk
JNJ is a stock built around pharmaceuticals & medical devices exposure, while MO is a stock built around tobacco exposure. Beta is 0.231 for JNJ and 0.495 for MO, making JNJ the less volatile of the two by this measure.
Security details
JNJ (Johnson & Johnson) is a stock. MO (Altria Group, Inc.) is a stock.
Enjoyed this page?
Do us a favor — if you found this comparison useful, please share it with a friend researching dividend investments.
Frequently asked questions
What is the current distribution yield for JNJ and MO?
JNJ currently distributes 1.92% and MO 6.10%, based on fund data updated September 2026. Distribution yield moves with both the payout and the share price, so check the as-of date before relying on either figure.
Is JNJ or MO better for dividend income?
It depends on your goals. MO currently offers the higher distribution yield, which means more income per dollar invested. However, a lower-yield fund may offer better total return or lower volatility. Consider your time horizon and risk tolerance.
What is the difference between JNJ and MO?
JNJ (Johnson & Johnson) is a stock built around pharmaceuticals & medical devices exposure, while MO (Altria Group, Inc.) is a stock built around tobacco exposure. They are issued by — and — respectively.
Can I hold both JNJ and MO?
Yes — nothing prevents holding both. Whether the combination actually diversifies depends on how much the underlying exposures overlap, which isn't fully measurable from the data on this page; review each security's holdings, sector, and strategy before treating them as complementary.
Is JNJ or MO safer?
By Dividend Vision's Distribution Safety Score — a rules-based 0–100 estimate of how resilient a distribution looks, where higher is safer — JNJ scores 100, MO scores 97, so JNJ's payout currently looks the more resilient of the two. JNJ has also shown lower price volatility (beta 0.23 vs 0.49 for MO). No score makes an investment risk-free — treat this as a screening signal, not a guarantee.
How much income does $10,000 in JNJ vs MO generate?
At current rates, $10,000 in JNJ would generate roughly $16.00 per month ($192.00 annually). The same in MO would produce about $50.83 per month ($610.00 annually).
Which has performed better historically, JNJ or MO?
JNJ has outpaced MO over the trailing twelve months, posting a 58.12% total return against 10.39%. The lead holds up over 10 years too: JNJ has compounded at 11.68% a year, against 7.32% for MO. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.
More comparisons to explore
Popular comparisons
JNJ vs MO — at a glance
Generated August 29, 2026.
Overview
Johnson & Johnson and Altria Group are dividend-paying stocks in distinct defensive sectors: pharmaceuticals and medical devices versus tobacco. JNJ emphasizes innovation and global healthcare exposure, while MO operates as a consolidated U.S. tobacco and wine business. The most obvious difference is yield: MO distributes 6.10% versus JNJ's 1.92%, a gap that reflects sector economics, regulatory headwinds, and capital allocation philosophy.
How they differ
MO's yield is more than three times JNJ's, driven by tobacco's mature, cash-generative business model and shrinking addressable market. JNJ trades at $275.23 with a beta of 0.231, making it less volatile than the broader market and reflecting the stability of healthcare demand; MO at $68.88 has a beta of 0.495, still defensive but notably more volatile. JNJ reinvests most earnings into R&D and acquisitions to drive long-term growth, while MO returns capital aggressively to shareholders through dividends and buybacks because its underlying cigarette volumes decline structurally. Both pay quarterly, but MO's higher payout ratio makes it a current-income machine, whereas JNJ targets total return driven by capital appreciation over decades.
Who each is best for
JNJ: Fits investors seeking steady, inflation-resistant dividend growth over a long horizon, with tolerance for modest near-term yield in exchange for exposure to innovation, global markets, and pricing power in essential healthcare products.
MO: Fits investors prioritizing current income with relatively low price volatility, who view tobacco's regulatory and litigation risks as already priced in and accept that dividend growth will be modest or negative in real terms.
Key risks to know
- Dividend sustainability at MO. U.S. cigarette unit sales have fallen steadily for decades. If volumes accelerate downward or regulation tightens, the company's ability to sustain a 6.10% yield while funding business maintenance becomes stressed; the payout ratio already leaves limited room for volume contraction.
- JNJ patent cliffs and pipeline risk. Blockbuster drugs lose exclusivity, creating revenue gaps that R&D must fill. Failure to advance late-stage candidates or deliver clinical wins could slow earnings growth and pressure the stock, which has historically driven total return more than dividends.
- Litigation and regulatory exposure for MO. Tobacco faces ongoing litigation (particularly around menthol), FDA regulation, and state tax increases. A major adverse ruling or sweeping regulatory change could impair cash flow unpredictably.
- Valuation and duration sensitivity for JNJ. At a 1.92% yield, JNJ's valuation rests heavily on growth and discount-rate assumptions; rising interest rates or a shift in investor preferences away from low-yielding defensive stocks could pressure the price independent of fundamentals.
Bottom line
If you need high current income and can tolerate tobacco-sector risks, MO's 6.10% yield is substantially more generous; if you prioritize capital stability, global diversification, and long-term dividend growth with lower volatility, JNJ's lower yield reflects a structurally superior market position. Past performance does not guarantee future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
Learn the method
The metrics behind this comparison, explained in the Academy.
Still deciding? Compare them against your own portfolio
See how each stock fits alongside your real holdings — forecast future income, analyze overlap, and gauge risk. Start a free 7-day Dividend Vision trial and make the call with your full portfolio in view.